Clinical TrialID 6753

Abscisic Acid Effects on Glucose Homeostasis and Insulin Sensitivity

NCT04722354

Pre Diabetes

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
6753
Evidence Id
6753
Core Evidence Id
6753
Source Clinical Trial Id
6743
Herb2 Clinical Trial Id
HBCT006743
Nct Id
NCT04722354
Title
Abscisic Acid Effects on Glucose Homeostasis and Insulin Sensitivity
Status
Active_Not_Recruiting
Phase
Phase 2
Study Result
No
Study Condition
Pre Diabetes
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: OTHER
Intervention
OTHER: Hyperinsulemic euglycemic clamp|PROCEDURE: Muscle Biopsy|DIETARY_SUPPLEMENT: Oral abscisic acid (ABA)|OTHER: Placebo
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Single
Intervention Purpose
Other
Gender
All
Age
Adult, Older_Adult
Enrollment
48
Outcome Measure
Monitoring adverse events, Adverse events will be monitored at each visit throughout the duration of the study., 10 weeks|Insulin sensitivity, Insulin sensitivity will be measured using hyperinsulinic euglycemic clamp, 4-6 hours
Sponsor Collaborator
AdventHealth Translational Research Institute|BioTherapeutics Inc.
Funded By
OTHER
Location
AdventHealth Translational Research Institute, Orlando, Florida, 32803, United States
Other Id
1545505
Start Date
2021-03-08
Primary Completion Date
2024-12
Completion Date
2024-12
First Posted
2021-01-25
Results First Posted
Last Update Posted
2024-06-21
Study Document
Study Url
https://clinicaltrials.gov/study/NCT04722354
Title Cn
Title En
Abscisic Acid Effects on Glucose Homeostasis and Insulin Sensitivity
Bilingual Status
semi_complete